ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013

In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches

September 3, 1976

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

HCFA Firm Against Reimbursement For Patients In Clinical Trials, Lasagna Committee Hears

March 24, 1989

NCAB Approves Grants For Action Plan On Breast Cancer

September 22, 1995

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990